This is an epidemiologic study on effect of hepatic steatosis on prognosis and outcomes of patients with chronic hepatitis B.
This is a multicenter, prospective and open-enrollment epidemiologic study. All the patients with chronic hepatisis B will be enrolled in the study and followed up after 1 year, 3 years and 5 years with a visit window of +1 month.
Study Type
OBSERVATIONAL
Enrollment
3,000
Zhangzhou Zhengxing Hospital
Zhangzhou, Fujian, China
Shandong Provincial Hospital
Ji'nan, Shandong, China
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Tianjin Second People's Hospital
Tianjin, Tianjin Municipality, China
liver cirrhosis
Time frame: 5 years
liver cancer
Time frame: 5 years
liver failure
Time frame: 5 years
type 2 diabetes
Time frame: 5 years
cardiovascular and cerebrovascular events
Time frame: 5 years
death
Time frame: 5 years
response of hepatic steatosis to anti-virus treatment
Time frame: 1 year
effect of hepatic steatosis on HBeAg negativation among patients without anti-virus treatment
Time frame: 1 year
effect of hepatic steatosis on HBsAg negativation among patients without anti-virus treatment
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, Zhejiang, China
Shanghai Xinhua Hospital
Shanghai, China